Literature DB >> 10745275

MAP kinase pathway signalling is essential for extracellular matrix determined mammary epithelial cell survival.

D Finlay1, V Healy, F Furlong, F C O'Connell, N K Keon, F Martin.   

Abstract

Mammary epithelial cells in primary cell culture require both growth factors and specific extracellular matrix (ECM)-attachment for survival. Here we demonstrate for the first time that inhibition of the ECM-induced Erk 1/Erk 2 (p42/44 MAPK) pathway, by PD 98059, leads to apoptosis in these cells. Associated with this cell death is a possible compensatory signalling through the p38 MAP kinase pathway the inhibition of which, by SB 203580, leads to a more rapid onset of apoptosis. This provides evidence for a hitherto undescribed Erk 1/Erk 2 to p38 MAP kinase pathway 'cross-talk' that is essential for the survival of these cells. The cell death associated with inhibition of these two MAP kinase pathways however, occurred in the presence of insulin that activates the classical PI-3 kinase-dependent Akt/PKB survival signals and Akt phosphorylation. Cell death induced by inhibition of the MAP kinase pathways did not affect Akt phosphorylation and may, thus, be independent of PI-3 kinase signalling.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10745275     DOI: 10.1038/sj.cdd.4400652

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  10 in total

1.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 2.  Functional roles of cytokines in infectious disease associated colorectal carcinogenesis.

Authors:  Ching Yi Ong; Eshtiyag Abdalla Abdalkareem; Boon Yin Khoo
Journal:  Mol Biol Rep       Date:  2022-01-04       Impact factor: 2.316

3.  PTEN overexpression suppresses proliferation and differentiation and enhances apoptosis of the mouse mammary epithelium.

Authors:  Joëlle Dupont; Jean Pierre Renou; Moshe Shani; Lothar Hennighausen; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines.

Authors:  A A Liem; M V C L Appleyard; M A O'Neill; T R Hupp; M P Chamberlain; A M Thompson
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

5.  Gene expression in the human mammary epithelium during lactation: the milk fat globule transcriptome.

Authors:  Patricia D Maningat; Partha Sen; Monique Rijnkels; Agneta L Sunehag; Darryl L Hadsell; Molly Bray; Morey W Haymond
Journal:  Physiol Genomics       Date:  2008-11-18       Impact factor: 3.107

6.  Antiangiogenic Activity of Acer tegmentosum Maxim Water Extract in Vitro and in Vivo.

Authors:  Eok-Cheon Kim; So Hun Kim; Shan-Ji Piao; Tack-Joong Kim; Kiho Bae; Han Sung Kim; Soon-Sun Hong; Byoung Ick Lee; Moonsuk Nam
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

7.  Upregulation of LAMB1 via ERK/c-Jun Axis Promotes Gastric Cancer Growth and Motility.

Authors:  Hana Lee; Won-Jin Kim; Hyeon-Gu Kang; Jun-Ho Jang; Il Ju Choi; Kyung-Hee Chun; Seok-Jun Kim
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

8.  Activation of adherent vascular neutrophils in the lung during acute endotoxemia.

Authors:  Vasanthi R Sunil; Agnieszka J Connor; Peihong Zhou; Marion K Gordon; Jeffrey D Laskin; Debra L Laskin
Journal:  Respir Res       Date:  2002-08-07

Review 9.  Application of insulin-like growth factor-1 in the treatment of inner ear disorders.

Authors:  Norio Yamamoto; Takayuki Nakagawa; Juichi Ito
Journal:  Front Pharmacol       Date:  2014-09-10       Impact factor: 5.810

10.  MicroRNA-520g promotes epithelial ovarian cancer progression and chemoresistance via DAPK2 repression.

Authors:  Jing Zhang; Lei Liu; Yunyan Sun; Jiandong Xiang; Dongmei Zhou; Li Wang; Huali Xu; Xiaoming Yang; Na Du; Meng Zhang; Qin Yan; Xiaowei Xi
Journal:  Oncotarget       Date:  2016-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.